We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 57.61%
This Fund
S&P 500
This Quarter Est. Return
+11.33%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$31.9B
AUM Growth
+$3.19B
Cap. Flow
+$655M
Cap. Flow %
2.06%
Top 10 Hldgs %
37.2%
Holding
1,711
New
132
Increased
1,102
Reduced
353
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 36.43%
2 Communication Services 10.67%
3 Consumer Discretionary 9.33%
4 Healthcare 6.07%
5 Financials 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQ icon
1351
iQIYI
IQ
$1.28B
$47.7K ﹤0.01%
18,639
+2,500
+15% +$5.54K
TRML
1352
DELISTED
Tourmaline Bio
TRML
$47.5K ﹤0.01%
993
+1
+0.1% +$28
HRB icon
1353
H&R Block
HRB
$6.87B
$47.3K ﹤0.01%
935
-147
-14% -$7.77K
TIGR
1354
UP Fintech Holding
TIGR
$818M
$47.1K ﹤0.01%
4,418
+862
+24% +$9.24K
GRFS
1355
Grifois
GRFS
$5.4B
$47K ﹤0.01%
4,716
+3
+0.1% +$30
CVAC
1356
DELISTED
CureVac
CVAC
$46.9K ﹤0.01%
8,705
+7
+0.1% +$38
ELVN icon
1357
Enliven Therapeutics
ELVN
$4.24B
$46.9K ﹤0.01%
2,290
+394
+21% +$7.94K
AMLX icon
1358
Amylyx Pharmaceuticals
AMLX
$2.6B
$46.8K ﹤0.01%
3,447
+4
+0.1% +$38
BILL icon
1359
BILL Holdings
BILL
$4.85B
$46.5K ﹤0.01%
878
+55
+7% +$2.55K
CURB
1360
Curbline Properties
CURB
$3.46B
$46.3K ﹤0.01%
2,074
+113
+6% +$2.55K
MIDD icon
1361
Middleby
MIDD
$5.38B
$45.9K ﹤0.01%
+345
New +$47.9K
ORIC icon
1362
Oric Pharmaceuticals
ORIC
$1.43B
$45.1K ﹤0.01%
3,755
+1,009
+37% +$10.6K
WVE icon
1363
Wave Life Sciences
WVE
$1.03B
$45K ﹤0.01%
6,152
+198
+3% +$1.6K
DVAX
1364
DELISTED
Dynavax Technologies
DVAX
$45K ﹤0.01%
4,534
-105
-2% -$1.09K
BAC.PRL icon
1365
Bank of America Series L
BAC.PRL
$4.02B
$44.8K ﹤0.01%
+35
New +$43.4K
PCRX icon
1366
Pacira BioSciences
PCRX
$945M
$44.8K ﹤0.01%
1,737
-52
-3% -$1.28K
VTMX icon
1367
Vesta Real Estate
VTMX
$3.21B
$44.6K ﹤0.01%
1,576
-139
-8% -$3.82K
INVA icon
1368
Innoviva
INVA
$1.5B
$44.5K ﹤0.01%
2,436
+11
+0.5% +$214
ACI icon
1369
Albertsons Companies
ACI
$5.83B
$44.2K ﹤0.01%
2,524
+625
+33% +$12.3K
VIST icon
1370
Vista Energy
VIST
$7.31B
$43.9K ﹤0.01%
1,275
-221
-15% -$9.14K
PUBM icon
1371
PubMatic
PUBM
$783M
$43.6K ﹤0.01%
5,264
-117
-2% -$1.19K
DOYU
1372
DouYu International Holdings
DOYU
$138M
$43.5K ﹤0.01%
+5,780
New +$45.2K
WB icon
1373
Weibo
WB
$1.91B
$43.2K ﹤0.01%
3,480
+521
+18% +$5.7K
PRAX icon
1374
Praxis Precision Medicines
PRAX
$10.8B
$43.1K ﹤0.01%
814
+27
+3% +$1.31K
TRVI icon
1375
Trevi Therapeutics
TRVI
$2.53B
$43.1K ﹤0.01%
4,708
+778
+20% +$5.83K

Similar funds

Mirae Asset Global Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Mirae Asset Global Investments held 1,711 positions worth $31.9B, up 11% from $28.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mirae Asset Global Investments's Q3 2025 filing shows 132 new, 1,102 increased, 353 reduced and 69 closed positions. Its largest new stake was Invesco S&P 500 Momentum ETF: 537,274 shares worth $65M. The largest sale was Vanguard S&P 500 ETF, an estimated $453M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Mirae Asset Global Investments's largest Q3 2025 buy was Invesco S&P 500 Momentum ETF: 537,274 shares worth $65M.
  • Mirae Asset Global Investments added most to NVIDIA in Q3 2025, an estimated $81.9M increase.
  • Mirae Asset Global Investments's biggest Q3 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $453M.
  • Mirae Asset Global Investments fully exited iShares S&P 100 ETF in Q3 2025, selling an estimated $58.9M.
  • Mirae Asset Global Investments's ten largest holdings make up 37% of its $31.9B portfolio in Q3 2025.
  • Mirae Asset Global Investments opened 132 new positions and closed 69 in Q3 2025.
  • Mirae Asset Global Investments's portfolio value rose 11% quarter-over-quarter to $31.9B.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.